AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT

FRIDAY, April 4, 2025-- For patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (allo-HCT), machine learning (ML) enhances risk stratification, according to a study published online March 27 in Blood.Juan Carlos...